Caribou Biosciences Inc - ESG Rating & Company Profile powered by AI
This page is a zero-cost Sustainability analysis covering Caribou Biosciences Inc. This dashboard includes a questions and answers table on Caribou Biosciences Inc. Full Sustainability analysis of Caribou Biosciences Inc can be accessed by signing up for free.
Caribou Biosciences Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 2.9; made up of an environmental score of 4.0, social score of 1.6 and governance score of 3.2.
2.9
Low ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| ... | ... | ... | |
| 1336 | SyneuRx International (Taiwan) Corp | 3.0 | Medium |
| 1336 | Sensorion SA | 3.0 | Medium |
| 1353 | Caribou Biosciences Inc | 2.9 | Medium |
| 1353 | Checkmate Pharmaceuticals Inc | 2.9 | Medium |
| 1353 | Atossa Therapeutics Inc | 2.9 | Medium |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Caribou Biosciences Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Caribou Biosciences Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes Caribou Biosciences Inc report the average age of the workforce?
Sign up for free to unlockDoes Caribou Biosciences Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Caribou Biosciences Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes Caribou Biosciences Inc disclose cybersecurity risks?
Sign up for free to unlockDoes Caribou Biosciences Inc offer flexible work?
Sign up for free to unlockDoes Caribou Biosciences Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Caribou Biosciences Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Caribou Biosciences Inc conduct supply chain audits?
Sign up for free to unlockDoes Caribou Biosciences Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Caribou Biosciences Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes Caribou Biosciences Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes Caribou Biosciences Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Caribou Biosciences Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Caribou Biosciences Inc disclose water use targets?
Sign up for free to unlockDoes Caribou Biosciences Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid Caribou Biosciences Inc have a product recall in the last two years?
Sign up for free to unlockDoes Caribou Biosciences Inc disclose incidents of discrimination?
Sign up for free to unlockDoes Caribou Biosciences Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Caribou Biosciences Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Caribou Biosciences Inc disclose parental leave metrics?
Sign up for free to unlockDoes Caribou Biosciences Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Caribou Biosciences Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Caribou Biosciences Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes Caribou Biosciences Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Caribou Biosciences Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Caribou Biosciences Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Caribou Biosciences Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes Caribou Biosciences Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Caribou Biosciences Inc disclose its waste policy?
Sign up for free to unlockDoes Caribou Biosciences Inc report according to TCFD requirements?
Sign up for free to unlockDoes Caribou Biosciences Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Caribou Biosciences Inc disclose energy use targets?
Sign up for free to unlockDoes Caribou Biosciences Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Caribou Biosciences Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Caribou Biosciences Inc
These potential risks are based on the size, segment and geographies of the company.
Caribou Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of genome-edited allogeneic cell therapies for the treatment of hematologic malignancies and solid tumors in the United States and internationally. Its lead product candidates are CB-010, an allogeneic anti-CD19 CAR-T cell therapy that is in phase 1 clinical trial to treat relapsed or refractory B cell non-Hodgkin lymphoma; and CB-011, an allogeneic anti-BCMA CAR-T cell therapy for the treatment of relapsed or refractory multiple myeloma. The company also develops CB-012, an allogeneic anti-CD371 CAR-T cell therapy for the treatment of relapsed or refractory acute myeloid leukemia; and CB-020, an allogeneic CAR-NK cell therapy for the treatment of solid tumors. It has collaboration with AbbVie Manufacturing Management Unlimited Company to develop CAR-T cell therapies. The company was incorporated in 2011 and is headquartered in Berkeley, California.